DE69527524D1 - Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen - Google Patents

Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen

Info

Publication number
DE69527524D1
DE69527524D1 DE69527524T DE69527524T DE69527524D1 DE 69527524 D1 DE69527524 D1 DE 69527524D1 DE 69527524 T DE69527524 T DE 69527524T DE 69527524 T DE69527524 T DE 69527524T DE 69527524 D1 DE69527524 D1 DE 69527524D1
Authority
DE
Germany
Prior art keywords
lung
animal
hyperinflated
perfluorocoles
mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69527524T
Other languages
English (en)
Inventor
Clark, Jr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tenax Therapeutics Inc
Original Assignee
Synthetic Blood International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthetic Blood International Inc filed Critical Synthetic Blood International Inc
Application granted granted Critical
Publication of DE69527524D1 publication Critical patent/DE69527524D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
DE69527524T 1994-05-13 1995-05-12 Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen Expired - Lifetime DE69527524D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/242,310 US5674913A (en) 1994-05-13 1994-05-13 Method for assisting normal breathing in a mammal having a lung disorder
PCT/US1995/005993 WO1995031191A1 (en) 1994-05-13 1995-05-12 Use of perfluorocarbons for assisting normal breathing in mammals having lung disorders

Publications (1)

Publication Number Publication Date
DE69527524D1 true DE69527524D1 (de) 2002-08-29

Family

ID=22914268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69527524T Expired - Lifetime DE69527524D1 (de) 1994-05-13 1995-05-12 Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen

Country Status (8)

Country Link
US (1) US5674913A (de)
EP (1) EP0758886B1 (de)
JP (1) JPH10505319A (de)
AT (1) ATE220901T1 (de)
AU (1) AU690277B2 (de)
CA (1) CA2190180C (de)
DE (1) DE69527524D1 (de)
WO (1) WO1995031191A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5628930A (en) * 1992-10-27 1997-05-13 Alliance Pharmaceutical Corp. Stabilization of fluorocarbon emulsions
US5840767A (en) * 1995-12-01 1998-11-24 Synthetic Blood International, Inc. Perfluorocarbons for biological gas exchange and method
US6167887B1 (en) * 1997-11-21 2001-01-02 Synthetic Blood International, Inc. Selected C-10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
CN1215834C (zh) * 2000-07-20 2005-08-24 佩尔夫托拉科研生产公众股份公司 一种用于医药目的的全氟有机化合物的乳液、其制备方法和利用其治疗和预防疾病的方法
EP1365068B1 (de) * 2002-05-10 2008-05-07 The Procter & Gamble Company Geprägtes Tissue mit abstehenden Oberflächenfasern und Verfahren zu dessen Herstellung
US8535691B2 (en) * 2006-02-16 2013-09-17 Peach Technologies, LLC. Perflurochemical treatment process and apparatus
WO2007134304A1 (en) * 2006-05-15 2007-11-22 Virginia Commonwealth University Methods and compositions for controlled and sustained production and delivery of peroxides
CN101646442B (zh) 2007-02-23 2013-09-04 21世纪国际新技术株式会社 血管痉挛的治疗剂或预防剂
US20090202617A1 (en) * 2008-02-13 2009-08-13 Ward Kevin R Gas based wound and tissue therapeutics
CA2729597C (en) * 2008-07-18 2018-01-16 Oxygen Biotherapeutics, Inc. Method of treating traumatic brain injury
US8343515B2 (en) 2008-11-25 2013-01-01 Oxygen Biotherapeutics, Inc. Perfluorocarbon gel formulations
US20100144597A1 (en) * 2008-12-10 2010-06-10 Ward Kevin R Novel combinatorial approaches to enhancing oxygen transport to tissues
WO2011014247A1 (en) * 2009-07-28 2011-02-03 Oxygen Biotherapeutics, Inc. Method to increase oxygen in male and female sexual organs through the topical use of perfluorocarbons
WO2012044963A2 (en) 2010-10-01 2012-04-05 Oxygen Biotherapeutics, Inc. Perfluorocarbons for use in treating pruritus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3911138B1 (en) * 1973-02-26 1996-10-29 Childrens Hosp Medical Center Artificial blood and method for supporting oxygen transport in animals
US4173654A (en) * 1977-01-03 1979-11-06 California Institute Of Technology Novel fluorohydrocarbons
JP2935519B2 (ja) * 1989-08-28 1999-08-16 シーキンス，ケイ・マイケル 超音波および／またはペルフルオロカーボン液での対流を介する肺癌高熱治療
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5146014A (en) * 1991-07-02 1992-09-08 Air Products And Chemicals, Inc. Perfluoroethyldimethyl cyclohexane
US5295953A (en) * 1992-05-26 1994-03-22 Hemagen/Pfc Method and apparatus for extracorporeal separation of fluorochemicals from whole blood of a patient

Also Published As

Publication number Publication date
US5674913A (en) 1997-10-07
CA2190180C (en) 2000-10-03
EP0758886B1 (de) 2002-07-24
JPH10505319A (ja) 1998-05-26
AU2549395A (en) 1995-12-05
CA2190180A1 (en) 1995-11-23
WO1995031191A1 (en) 1995-11-23
AU690277B2 (en) 1998-04-23
ATE220901T1 (de) 2002-08-15
EP0758886A1 (de) 1997-02-26

Similar Documents

Publication Publication Date Title
DE69527524D1 (de) Verwendung von perfluorokohlenstoffen zur unterstützung der normalen atmung in säugetieren mit lungenerkrankungen
Downes The historical evolution, current status, and prospective development of pediatric critical care
Dörges et al. The laryngeal tube S: a modified simple airway device
Auerbach et al. Inadequate oxygenation and ventilation using the esophageal gastric tube airway in the prehospital setting
DE69432708D1 (de) Vorrichtung zur unterstützung bei kardiopulmonaler wiederbelebung
DE69214467T2 (de) Verwendung von Thiazolidin-4-carboxylatderivaten zur Behandlung von Lungenerkrankungen
Koch et al. Bronchoscopic findings in post-obstructive pulmonary oedema
ATE143260T1 (de) Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen
Ratliff et al. Re-expansion Pulmonary Edema: A Rare But Life-Threatening Complication of a Commonly Performed Minor Surgical Procedure
WEST et al. Pulmonary function in cystic fibrosis of the pancreas
Idris Reassessing the need for ventilation during CPR
ASMUNDSSON et al. Complications of acute respiratory failure
Thee et al. Laryngeal tube S II, laryngeal tube S disposable, Fastrach laryngeal mask and Fastrach laryngeal mask disposable during elective surgery: a randomized controlled comparison between reusable and disposable supraglottic airway devices
O'Toole et al. Extracorporeal membrane oxygenation in the treatment of inhalation injuries
Glasser et al. The use of spontaneous ventilation with constant-positive airway pressure in the treatment of salt water near drowning
Eipe et al. Submental intubation for cancrum oris: a case report
Vogelhiut et al. Prolonged endotracheal intubation
Of Oxygen therapy
Moore et al. Inhalational versus intravenous induction. A survey of emergency anaesthetic practice in the United Kingdom
Schoenstadt et al. A re-examination of the ventilating bronchoscope
REYNOLDS et al. Permissive hypercapnia and pressure-controlled ventilation as treatment of severe adult respiratory distress syndrome in a pediatric burn patient
Gilbertson Before intensive therapy?
ATE145827T1 (de) Verfahren zur hemmung der sauerstofftoxizität in den lungen
Gerancher et al. Nasal BiPAP treats hypoxia from postobstructive pulmonary edema
Reynolds Respiratory Distress Syndrome: Methods of Mechanical Ventilation for Hyaline Membrane Disease

Legal Events

Date Code Title Description
8332 No legal effect for de